1. Real‐world resource use and costs of adjuvant treatment for stage III colon cancer. (25th December 2013) Authors: van Gils, C.W.M.; de Groot, S.; Tan, S.S.; Redekop, W.K.; Koopman, M.; Punt, C.J.A.; Uyl‐de Groot, C.A. Journal: European journal of cancer care Issue: Volume 24:Number 3(2015:May) Page Start: 321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The cost‐effectiveness of dapagliflozin compared to DPP‐4 inhibitors in the treatment of type 2 diabetes mellitus in the Netherlands. Issue 4 (18th September 2020) Authors: Van der Linden, N.; Van Olst, S.; Nekeman, S.; Uyl‐de Groot, C.A. Journal: Diabetic medicine Issue: Volume 38:Issue 4(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗